Drug Shortage Report for ACT RISPERIDONE
| Report ID | 3337 |
| Drug Identification Number | 02282623 |
| Brand name | ACT RISPERIDONE |
| Common or Proper name | RISPERIDONE |
| Company Name | ACTAVIS PHARMA COMPANY |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 3MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-17 |
| Estimated end date | 2017-06-07 |
| Actual end date | 2017-08-01 |
| Shortage status | Resolved |
| Updated date | 2017-09-19 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.